Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

Background Elevated lipoprotein(a) is a well‐established risk factor for atherosclerotic vascular disease but is not measured in routine clinical care. Screening of high lipoprotein(a) in individuals with moderate elevations of low‐density lipoprotein cholesterol (LDL‐C) may identify individuals at...

Full description

Bibliographic Details
Main Authors: Mehdi Afshar, Jian Rong, Yang Zhan, Hao Yu Chen, James C. Engert, Allan D. Sniderman, Martin G. Larson, Ramachandran S. Vasan, George Thanassoulis
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiovascular disease
dyslipidemia
Framingham
lipoprotein(a)
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014711

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014711

Similar Items